DOTA-TOC-95【204318-14-9】 Percursor for radiolabelled DOTA-TOC
Add to Inquiry List
View Inquiry List

Product Name: DOTA-TOC
Synonyms: 2,2',2''-(10-(2-(((R)-1-(((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-4- (((2R,3R)-1,3-dihydroxybutan-2-yl)carbamoyl)-16-(4-hydroxybenzyl)-7-((S)-1-hydroxyethyl)-6,9,1 2,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylprop an-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
CAS No.: 204318-14-9
Molecular Formula: C65H92N14O18S2
Molecular weight: 1421.64
Application: Percursor for radiolabelled DOTA-TOC
Presentation Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.

  • Care must be taken when handling this product.
  • Do not contact skin or eyes.
  • Do not ingest or inhale.
  • Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
  • It shall be only used by qualified personnel and only for research.

DOTA-TOC-95-0.1x        0.1mg per vial
DOTA-TOC-95-0.25x       0.25mg per vial
DOTA-TOC-95-0001x       1mg per vial
note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial
*Customized dispensing is available